Investo Capital
Niels Jernes Vej 10, Aalborg Øst, North Jutland, 9220, Denmark
Overview
Investo Capital is a Danish venture capital firm based in Aalborg. They invest in carefully selected Danish early-growth companies within tech business areas in the broad sense. The target group is innovative companies with proof of business, strategic thinking, and strong growth prospects in Denmark. Strategic corporate concepts and competent management are essential features. The investment focus is Technology, IT, SAAS- and med-tech.
- Total investments
- 3
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- VentriJect
Participated · Equity · Aug 2025
VentriJect's core product is the Seisomofit, a CE-marked medical device that uses seismocardiography to detect chest-wall vibrations and estimate VO2max. The system delivers an estimated VO2max in under three minutes without exercise and provides results to users through the VentriJect app. The company was founded in 2018 as a spinout from Aalborg University and had a commercialised product by 2021. VentriJect says its technology has both medical and fitness applications, which supported rapid expansion across multiple European markets and existing customers. It has signed distributors in Denmark, the Netherlands, Sweden, Switzerland and the UK, and is in final negotiations with several European healthcare providers. The company is also exploring US market entry to access over 55,000 health clubs and the world’s largest healthcare market. VentriJect completed a €1.7 million funding round to support further market expansion.
- Brainreader
Participated · Equity · May 2025
Brainreader’s core product, Neuroreader, is a CE-marked and FDA-cleared software platform that delivers automated volumetric analysis of brain MRI scans to aid radiologists and neurologists. The platform integrates into standard workflows to help detect subtle changes in brain structure faster and with greater precision. Neuroreader is used in clinical practice to support diagnosis and monitoring of Alzheimer’s disease, traumatic brain injury, and other neurodegenerative disorders. Brainreader plans to accelerate a global rollout and scale commercial operations, with particular focus on the US healthcare market. The company also intends to continue development of new features and clinical applications for its platform. Recent regulatory and reimbursement dynamics—US adoption of CPT codes for brain volumetry and EU MDR compliance—are cited as tailwinds for broader clinical adoption.
- Dryp
Led · Equity · Apr 2022
Dryp builds sensor and IoT-based monitoring solutions that give waterworks and wastewater companies access to data to optimize operations and planning. Its products aim to prevent sewer overflow and reduce congestion in drainage systems. The company emphasizes simplified installation, maintenance and management of its sensor solutions for utilities. Dryp combines IoT technology with big data to help utilities make operational and planning decisions. Founded in 2019, the company is led by CEO Peter Rasch and co-founder Malte Ahm. Financially, Dryp has raised capital previously from Trifork in 2021 and completed a new equity raise in this round.
Team
No current team members are available.